185 related articles for article (PubMed ID: 17210941)
1. Use of modeling to evaluate the cost-effectiveness of cancer screening programs.
Knudsen AB; McMahon PM; Gazelle GS
J Clin Oncol; 2007 Jan; 25(2):203-8. PubMed ID: 17210941
[TBL] [Abstract][Full Text] [Related]
2. Examining the cost-effectiveness of cancer screening promotion.
Andersen MR; Urban N; Ramsey S; Briss PA
Cancer; 2004 Sep; 101(5 Suppl):1229-38. PubMed ID: 15316909
[TBL] [Abstract][Full Text] [Related]
3. Dissecting cost-effectiveness analysis for preventive interventions: a guide for decision makers.
Teutsch SM; Murray JF
Am J Manag Care; 1999 Mar; 5(3):301-5. PubMed ID: 10351026
[TBL] [Abstract][Full Text] [Related]
4. The Philadelphia High-School STD Screening Program: key insights from dynamic transmission modeling.
Fisman DN; Spain CV; Salmon ME; Goldberg M
Sex Transm Dis; 2008 Nov; 35(11 Suppl):S61-5. PubMed ID: 18607306
[TBL] [Abstract][Full Text] [Related]
5. Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis.
Ginsberg GM; Edejer TT; Lauer JA; Sepulveda C
Vaccine; 2009 Oct; 27(43):6060-79. PubMed ID: 19647813
[TBL] [Abstract][Full Text] [Related]
6. Developing and testing a cost-assessment tool for cancer screening programs.
Subramanian S; Ekwueme DU; Gardner JG; Trogdon J
Am J Prev Med; 2009 Sep; 37(3):242-7. PubMed ID: 19666160
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
[TBL] [Abstract][Full Text] [Related]
9. Methodological issues in the economic analysis of cancer treatments.
Tappenden P; Chilcott J; Ward S; Eggington S; Hind D; Hummel S
Eur J Cancer; 2006 Nov; 42(17):2867-75. PubMed ID: 17023160
[TBL] [Abstract][Full Text] [Related]
10. Estimating production costs in the economic evaluation of health-care programs.
Herrero C; Moreno-Ternero JD
Health Econ; 2009 Jan; 18(1):21-35. PubMed ID: 18264993
[TBL] [Abstract][Full Text] [Related]
11. Decision science and cervical cancer.
Cantor SB; Fahs MC; Mandelblatt JS; Myers ER; Sanders GD
Cancer; 2003 Nov; 98(9 Suppl):2003-8. PubMed ID: 14603536
[TBL] [Abstract][Full Text] [Related]
12. Randomized clinical trials for cancer screening: rationale and design considerations for imaging tests.
Black WC
J Clin Oncol; 2006 Jul; 24(20):3252-60. PubMed ID: 16829649
[TBL] [Abstract][Full Text] [Related]
13. [Allocating resources for cancer control--resolving multicriteria decision-making using the analytic hierarchy process].
Gróf A
Magy Onkol; 2007; 51(3):197-208. PubMed ID: 17922059
[TBL] [Abstract][Full Text] [Related]
14. [Public health problems related to chemoprevention of cancers].
Schaffer P; Allemand H
Bull Cancer; 1995 Jul; 82 Suppl 3():213s-223s. PubMed ID: 7492835
[TBL] [Abstract][Full Text] [Related]
15. A perspective from countries using organized screening programs.
Miles A; Cockburn J; Smith RA; Wardle J
Cancer; 2004 Sep; 101(5 Suppl):1201-13. PubMed ID: 15316915
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women.
Kwon JS; Lu KH
Obstet Gynecol; 2008 Jul; 112(1):56-63. PubMed ID: 18591308
[TBL] [Abstract][Full Text] [Related]
17. Basic issues in population screening for cancer.
Cole P; Morrison AS
J Natl Cancer Inst; 1980 May; 64(5):1263-72. PubMed ID: 6767876
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of prostate cancer screening with prostate-specific antigen.
Imamura T; Yasunaga H
Int J Urol; 2008 Apr; 15(4):285-8. PubMed ID: 18380812
[TBL] [Abstract][Full Text] [Related]
19. Methods for conducting systematic reviews of evidence on effectiveness and economic efficiency of interventions to increase screening for breast, cervical, and colorectal cancers.
Baron RC; Rimer BK; Coates RJ; Kerner J; Mullen PD; Chattopadhyay S; Briss PA;
Am J Prev Med; 2008 Jul; 35(1 Suppl):S26-33. PubMed ID: 18541185
[No Abstract] [Full Text] [Related]
20. [Economic criteria in assessing the efficacy of the fight against cancer].
Diatchenko OT; Shabashova NIa
Vopr Onkol; 1988; 34(12):1411-21. PubMed ID: 3146159
[No Abstract] [Full Text] [Related]
[Next] [New Search]
